T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.
about
Chimeric antigen receptor T-cell therapy for solid tumorsVirotherapy: cancer gene therapy at last?The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic MalignanciesThe immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.Exploiting natural killer group 2D receptors for CAR T-cell therapy.Immunotherapy for advanced melanoma: future directions.Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated Mice.Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects.Tumor-targeting domains for chimeric antigen receptor T cells.Strain-dependent Lethal Toxicity in NKG2D Ligand-targeted CAR T-cell Therapy.Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice.Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation.Practical considerations for chimeric antigen receptor design and delivery.Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy.Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications.'Atypical' CAR T cells: NKG2D and Erb-B as examples of natural receptor/ligands to target recalcitrant solid tumors.Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy.Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells.NKG2D Ligands-Critical Targets for Cancer Immune Escape and TherapyThe Paradoxical Role of NKG2D in Cancer Immunity
P2860
Q26750908-ED428700-ACE5-461B-A79E-8030F4DE7A4CQ28066228-9A80EC9C-B80F-46EE-B7F1-393D8BD469DAQ36547199-8EE62434-833A-47B4-95D0-7BF106BEF071Q37622429-4BC059A1-A169-4D33-93FB-359A24B65923Q38671184-28E8A026-ED50-4EBD-BF12-B9D9AC37AD94Q38711163-560565D5-D874-4F6E-A198-DD587D44C3A8Q38730881-FF80D3C0-4763-4C02-B65E-7949BE93CA67Q38756750-FA11DB84-F67A-40C6-81AF-909986D28E08Q38770555-819E5DB5-E99B-4781-859A-09C672D6A8DEQ39045535-867CE5C5-C38C-400A-B550-A0327FCB22F6Q39790928-24816D1C-A5BE-4B34-9075-78CE72598456Q40631295-6D37763B-406F-409B-83C4-A9E78D853AE0Q41067927-63463E55-4AF9-4E27-9EE9-C77483FE8C48Q45868559-4D9B7319-B4A9-4EAF-9947-D62090C80CCEQ47216941-437685B1-E14F-4E1F-9898-BE01F1FFCCB5Q47561397-977EAB4A-5154-4DC2-841A-682BA0C7BF19Q47849932-C08959C4-ACFD-4EA6-B4B7-70B1DEE2731BQ50199706-8436A4FE-1D91-4D40-81B7-7ED78721BDC0Q55510390-C851C024-4976-4E5C-AE73-3A5FD704B47EQ58750637-2267D4A2-97B4-42FC-A673-2ECED30A289AQ58785685-50DB5A8B-F6E7-494A-AE4C-6CDA67B50E9D
P2860
T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
T Cells Engineered With Chimer ...... splay Lethal Toxicity in Mice.
@ast
T Cells Engineered With Chimer ...... splay Lethal Toxicity in Mice.
@en
type
label
T Cells Engineered With Chimer ...... splay Lethal Toxicity in Mice.
@ast
T Cells Engineered With Chimer ...... splay Lethal Toxicity in Mice.
@en
prefLabel
T Cells Engineered With Chimer ...... splay Lethal Toxicity in Mice.
@ast
T Cells Engineered With Chimer ...... splay Lethal Toxicity in Mice.
@en
P2093
P2860
P356
P1433
P1476
T Cells Engineered With Chimer ...... splay Lethal Toxicity in Mice.
@en
P2093
Anna Dvorkin-Gheva
Brian Rabinovich
Daniela G M Tantalo
Galina F Denisova
Heather VanSeggelen
Jacek M Kwiecien
Joanne A Hammill
Yonghong Wan
P2860
P304
P356
10.1038/MT.2015.119
P577
2015-06-30T00:00:00Z